发明名称 QUINAZOLINONE-1-ALKANOIC ACIDS
摘要 Cpds. of formula (I) and their quat. salts with alkyl halides, alkali (ne earth) metal salts and the amine salt, aminoalcohol salts and aminoacid salts are new. In (I) R1 is H, NH2 or N02; R2 is H, alkyl, cycloalkyl, cycloalkylalkyl, haloalkyl or bicycloalkyl; R3 and R4 are H, lower alkyl, or aryl (opt. substd. by alkyl, lower alkoxy or OH); R5 is H, lower alkyl, or opt. substd. benzyl, provided that when R5 is other than H, the cpd. is a quat. salt; X is benzyl, COOH, alkoxycarbonyl, CN, CONH2, methane sulphonyl, formyl, alkanoyl, aroyl, heteroaroyl or heteroaryl; and Y and Z are H or OH, at least one being OH and when both are OH, they are in the 5,6- or 6,7- posn. Intermediates of formula (II) are also new. (R6 is lower alkyl; and R7 is H or is absent). Cpds. (I) are renal vasodilators and cardiovascular agents, and some intermediates in their prepn. are cardiotonic agents. Dose is 15-300 mg/kg.
申请公布号 PH21757(A) 申请公布日期 1988.02.18
申请号 PH19130000323 申请日期 1985.05.24
申请人 ORTHO PHARMACEUTICAL CORPORATION 发明人 VICTOR T. BANDURCO;SEYMOUR D. LEVINE;DENNIS M. MULVEY;ALFONSO J. TOBIA
分类号 A61K;A61K31/395;A61K31/495;A61K31/505;A61K31/80;C07D;C07D239/00;C07D239/10;C07D239/22;C07D239/36;C07D239/72;C07D239/80;C07D401/06;C07D401/14;C07D405/06;C07D405/14;C07D409/06;C07D409/14;C07D417/06;C07D417/14 主分类号 A61K
代理机构 代理人
主权项
地址
您可能感兴趣的专利